Scholarlink

Background/aim <p>In fever of unknown origin (FUO), despite comprehensive evaluation a substantial proportion of patients may remain without a definitive diagnosis. Herein, we aimed to analyse the disease course, mortality rate, final diagnosis, and the workup performed to reach final diagnosis in fever of unknown origin without final diagnoses (FUOWFD) cases.</p> Materials and methods <p>The roster of patients with FUOWFD was obtained from a previously published multicenter study. Subsequently, additional data was gathered retrospectively from each cooperating center.</p> Results <p>The follow-up data for 79 cases from 11 centers were included. While being considered as FUOWFD: 100% were performed biochemistry and microbiology, 78.5% for rheumatological markers, 33% for oncological markers, and 97.5% for radiological investigations. Other medical departments were consulted in 64.5% of the cases and invasive diagnostic procedures were performed in 27.8%. During the follow-up, 73 cases (92.4%) saw their fever resolve. Among these, 70 cases’ fever resolved within the first three months. In total, two patients (2.5%) received a definitive diagnosis during the follow-up period. After 6 months and 12 months follow up, the all-cause mortality rate was 3.8%. Notably, none of the three cases that experienced mortality by day 365 had received a final diagnosis for FUO.</p> Conclusion <p>The diagnostic process for FUO cases who remain undiagnosed exhibits substantial heterogeneity. The majority of patients experience spontaneous recovery, and the mortality rate is relatively low. Infectious causes are the most frequently encountered contributors to the FUO cases who remain undiagnosed.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Follow-up, diagnosis, and outcomes of fever of unknown origin cases in whom no diagnosis was established after initial evaluation: an ID-IRI (Infectious Diseases - International Research Initiative) observational retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月11日

查看全文
  • Umran Elbahr,
  • Hakan Erdem,
  • Amel Letaief,
  • Svjetlana Grgić,
  • Lysien Ivania Zambrano,
  • Wissal Ben Yahia,
  • Bilal Ahmad Rahimi,
  • Magdalena Baymakova,
  • Reham Khedr,
  • Emmanuel Nsutebu,
  • Gamze Şanlıdağ,
  • Meliha Meriç Koç,
  • Serkan Öncü,
  • Kostadin Poposki,
  • Gülden Eser-Karlıdağ,
  • Oğuz Reşat Sipahi

摘要

Background/aim

In fever of unknown origin (FUO), despite comprehensive evaluation a substantial proportion of patients may remain without a definitive diagnosis. Herein, we aimed to analyse the disease course, mortality rate, final diagnosis, and the workup performed to reach final diagnosis in fever of unknown origin without final diagnoses (FUOWFD) cases.

Materials and methods

The roster of patients with FUOWFD was obtained from a previously published multicenter study. Subsequently, additional data was gathered retrospectively from each cooperating center.

Results

The follow-up data for 79 cases from 11 centers were included. While being considered as FUOWFD: 100% were performed biochemistry and microbiology, 78.5% for rheumatological markers, 33% for oncological markers, and 97.5% for radiological investigations. Other medical departments were consulted in 64.5% of the cases and invasive diagnostic procedures were performed in 27.8%. During the follow-up, 73 cases (92.4%) saw their fever resolve. Among these, 70 cases’ fever resolved within the first three months. In total, two patients (2.5%) received a definitive diagnosis during the follow-up period. After 6 months and 12 months follow up, the all-cause mortality rate was 3.8%. Notably, none of the three cases that experienced mortality by day 365 had received a final diagnosis for FUO.

Conclusion

The diagnostic process for FUO cases who remain undiagnosed exhibits substantial heterogeneity. The majority of patients experience spontaneous recovery, and the mortality rate is relatively low. Infectious causes are the most frequently encountered contributors to the FUO cases who remain undiagnosed.

Clinical trial number

Not applicable.